REG - Hikma Pharmaceutical - Director/PDMR Shareholding
31/05/2023 15:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230531:nRSe2161Ba&default-theme=true
RNS Number : 2161B Hikma Pharmaceuticals Plc 31 May 2023
Hikma Pharmaceuticals PLC - LTIP and EIP Awards
LONDON, 31 May 2023: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)
(LEI: 549300BNS685UXH4JI75) announces that the Remuneration Committee made the
following conditional awards under the Hikma Pharmaceuticals PLC 2023 Long
Term Incentive Plan (the "LTIP"); the 2014 Executive Incentive Plan (the
"EIP") to Persons Discharging Managerial Responsibility ("PDMR") of the
Company. No consideration was paid for the grant of the awards.
Awards under the LTIP were made on 30 May 2023 based on a price of £18.43 per
Ordinary Share (being the average mid-market Ordinary Share price for the for
the 5-working day period prior to 30 May 2023, in accordance with the LTIP
rules) (the "LTIP Awards"). The vesting of the LTIP Awards is subject to the
continued employment of the PDMRs, malus and clawback provisions and the
satisfaction of performance conditions set by the Remuneration Committee of
the Company. The LTIP Awards will normally vest on the later of the third
anniversary of the date of grant and the determination of the performance
conditions. The LTIP Awards are then subject to an additional two-year holding
period.
Awards under the EIP were made on 30 May 2023 based on a price of £15.15 per
Ordinary Share (being the average mid-market Ordinary Share price for the
30-day period prior to 31 December 2022, in accordance with the EIP rules)
(the "EIP Awards"). All EIP Awards are subject to malus and clawback
provisions. EIP Element B Awards will normally vest on the second anniversary
of the date of grant, subject to continued employment, and are then subject to
an additional three-year holding period. EIP Element C Awards will normally
vest on the third anniversary of the date of grant, subject to continued
employment, and are then subject to an additional two-year holding period.
This notification is made under Article 19(1) of the EU Market Abuse
Regulation 596/2014 as it forms part of domestic law by virtue of the European
Union (Withdrawal) Act 2018 ("MAR"). The information set out below is provided
in accordance with the requirements of Article 19(3) of MAR.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman and Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 132,783 Shares
Nil EIP Award, Element B: 31,679 Shares
Nil EIP Award, Element C: 19,761 Shares
d) Aggregated information Price(s): nil
Volume(s): 184,223
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Mazen Darwazah
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 105,233 Shares
Nil EIP Award, Element B: 36,171 Shares
Nil EIP Award, Element C: 20,650 Shares
d) Aggregated information Price(s): nil
Volume(s): 162,054
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Bassam Kanaan
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 76,130 Shares
Nil EIP Award, Element B: 28,647 Shares
Nil EIP Award, Element C: 20,982 Shares
d) Aggregated information Price(s): nil
Volume(s): 125,759
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 74,699 Shares
Nil EIP Award, Element B: 28,833 Shares
Nil EIP Award, Element C: 22,209 Shares
d) Aggregated information Price(s): nil
Volume(s): 125,741
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Riad Mishlawi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 75,339 Shares
Nil EIP Award, Element B: 36,371 Shares
Nil EIP Award, Element C: 30,749 Shares
d) Aggregated information Price(s): nil
Volume(s): 142,459
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Majda Labadi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 50,301 Shares
Nil EIP Award, Element B: 18,836 Shares
Nil EIP Award, Element C: 13,796 Shares
d) Aggregated information Price(s): nil
Volume(s): 82,933
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Susan Ringdal
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 38,409 Shares
Nil EIP Award, Element B: 15,925 Shares
Nil EIP Award, Element C: 11,664 Shares
d) Aggregated information Price(s): nil
Volume(s): 65,998
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Brian Hoffmann
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Brian Hoffmann
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 54,422 Shares
Nil EIP Award, Element B: 12,233 Shares
Nil EIP Award, Element C: 8,302 Shares
d) Aggregated information Price(s): nil
Volume(s): 74,957
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Hussein Arkhagha
1 Details of the person discharging managerial responsibilities / person
closely associated
a) Name Hussein Arkhagha
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type
of instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and EIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP Award: 41,408 Shares
Nil EIP Award, Element B: 15,983 Shares
Nil EIP Award, Element C: 12,406 Shares
d) Aggregated information Price(s): nil
Volume(s): 69,797
e) Date of the transaction 30 May 2023
f) Place of the transaction Outside a trading venue
Helen Middlemist
Deputy Company Secretary
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBSGDUCBXDGXBRecent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement